These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5540713)

  • 1. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
    Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1971 Feb; 43(2):299-309. PubMed ID: 5540713
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
    Miller NE; Clifton-Bligh P; Nestel PJ
    J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol metabolism in patients with coronary heart disease.
    Miettinen TA
    Ann Clin Res; 1971 Dec; 3(6):313-22. PubMed ID: 5156891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G
    Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 6. Probucol in the long-term treatment of hypercholesterolaemia.
    Polachek AA; Katz HM; Sack J; Selig J; Littman ML
    Curr Med Res Opin; 1973; 1(6):323-30. PubMed ID: 4589404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 9. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 12. Probucol, a new cholesterol lowering drug.
    Nash DT
    J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 14. Biphenabid (Probucol): a new hypocholesterolemic agent.
    Kalams Z; Dacquisto M; Kornett GS
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 16. Are massive diet fat heart and coronary drug studies justified? A critical commentary.
    Roberts HJ
    Angiology; 1968 Dec; 19(11):652-64. PubMed ID: 4317984
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effects of clofibrate (Atromid-S) on serum lipids in man.
    Hunninghake DB; Tucker DR; Azarnoff DL
    Circulation; 1969 May; 39(5):675-83. PubMed ID: 5787318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of essential hypercholesteremia?].
    Schettler G
    Dtsch Med Wochenschr; 1968 Sep; 93(37):1779. PubMed ID: 5681549
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocrine and metabolic indices during administration of a lipophilic bis-phenol, probucol.
    Danowski TS; Vester JW; Sunder JH; Gonzalez AR; Khurana RC; Jung Y
    Clin Pharmacol Ther; 1971; 12(6):929-34. PubMed ID: 5134996
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.
    Miettinen TA
    Atherosclerosis; 1972; 15(2):163-76. PubMed ID: 4666121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.